Pancreas removal and islet cell transplant for chronic pancreatitis
Part of Digestive system clinical trials.
This study tests a surgery that removes the entire pancreas and then transplants your own insulin-making cells (islet cells) back into your liver. It aims to relieve chronic pancreatitis pain while reducing the risk of diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You need a diagnosis of chronic pancreatitis or recurrent acute pancreatitis that has not improved with other treatments.
- You must have ongoing abdominal pain for more than 6 months that requires strong painkillers or affects your daily life.
- You must not have diabetes or have enough insulin-producing cells (C-peptide positive).
- You must be in generally good health (able to carry out daily activities) and have a life expectancy of more than 2 years.
- You must be free of alcohol and tobacco use for at least 6 months before the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well a treatment works after islet cell transplantation done for people with long-term (chronic) pancreatitis. It may help doctors better understand graft (transplant) function and how to choose the best approach and follow-up.
This Phase 1 study tests a new cell-based treatment to reduce pain caused by chronic pancreatitis. It’s designed mainly to check safety first, and it may help people with ongoing, opioid-stable pancreatic pain.
This study looks at how the pancreas affects blood sugar and diabetes. It may help find better ways to prevent or treat type 2 diabetes.
This study collects health information and tissue samples from people with pancreatic cancer or other pancreatic conditions. Your participation may help researchers better understand these diseases and improve future care.
This trial removes the whole pancreas in people with certain pancreatic tumors and then transplants the patient's own insulin-making cells (islets) into the liver. The goal is to prevent or reduce diabetes after surgery.
This study looks at outcomes after a procedure called TPIAT (total pancreatectomy with islet auto-transplantation), which aims to improve insulin function and blood-sugar control. It may help doctors better understand how people do over time after the procedure.
Hear when a new Chronic Pancreatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.